Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Androgen-independent Prostate Cancer”

129 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 129 results

Large-scale testing (Phase 3)Ended earlyNCT00024167
What this trial is testing

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
M.D. Anderson Cancer Center 265
Testing effectiveness (Phase 2)Study completedNCT00919035
What this trial is testing

Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 21
Testing effectiveness (Phase 2)Study completedNCT00569153
What this trial is testing

Safety Study of TAK-700 in Subjects With Prostate Cancer.

Who this might be right for
Prostatic Neoplasms
Millennium Pharmaceuticals, Inc. 123
Testing effectiveness (Phase 2)Study completedNCT00134355
What this trial is testing

Study of PTK787 in the Treatment of Patients With Non-Metastatic Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 5
Testing effectiveness (Phase 2)Ended earlyNCT00179738
What this trial is testing

A Multicenter, Single-Arm, Open-Label, Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide (Revlimid, CC-5013) in Subjects With Androgen Independent Prostate Cancer.

Who this might be right for
Prostate Cancer
Celgene Corporation 40
Testing effectiveness (Phase 2)Study completedNCT01540071
What this trial is testing

Trial of NRX 194204 in Castration- and Taxane-Resistant Prostate Cancer

Who this might be right for
Castration Resistant Prostate Cancer
Io Therapeutics 38
Testing effectiveness (Phase 2)Ended earlyNCT00494338
What this trial is testing

Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Sanofi 6
Testing effectiveness (Phase 2)Study completedNCT00014352
What this trial is testing

Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer

Who this might be right for
Prostate CancerThromboembolism
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00715078
What this trial is testing

To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen

Who this might be right for
Prostate Cancer
Dendreon 122
Testing effectiveness (Phase 2)Study completedNCT00814788
What this trial is testing

Bicalutamide With or Without Everolimus in Treating Patients With Recurrent or Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, Davis 24
Testing effectiveness (Phase 2)Ended earlyNCT00753220
What this trial is testing

Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Bostwick Laboratories 7
Early research (Phase 1)Study completedNCT00006380
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Large-scale testing (Phase 3)UnknownNCT00043576
What this trial is testing

ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

Who this might be right for
Prostate Cancer
Novacea 250
Not applicableWithdrawnNCT00559481
What this trial is testing

Ketoconazole, Dexamethasone, and Hydrocortisone in Treating Patients With Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy

Who this might be right for
Prostate Cancer
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00096499
What this trial is testing

SB-715992 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Docetaxel or Paclitaxel

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00520481
What this trial is testing

Study With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the Prostate
Eli Lilly and Company 41
Early research (Phase 1)Study completedNCT00424385
What this trial is testing

Study Combining Imatinib Mesylate (Gleevec) With Sorafenib in Patients With Androgen-independent Prostate Cancer (AIPC)

Who this might be right for
Prostate Cancer
Oncology Specialists, S.C. 17
Early research (Phase 1)Study completedNCT00186108
What this trial is testing

A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
Stanford University 23
Testing effectiveness (Phase 2)Ended earlyNCT05551117
What this trial is testing

Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

Who this might be right for
Castration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more
MacroGenics 192
Testing effectiveness (Phase 2)Study completedNCT00964002
What this trial is testing

Efavirenz in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Institut Bergonié 61
Next Page